Litcius/Paper detail

The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy

Satoshi Kano, Daisuke Kawakita, Yoshitaka Honma, Hideaki Takahashi, Masato Nakaguro, Yoshitaka Utsumi, Natsuki Saigusa, Toyoyuki Hanazawa, Kiyoaki Tsukahara, Takuro Okada, Kenji Okami, Keisuke Yamazaki, Yushi Ueki, Yuki Saito, Hiroyuki Ozawa, Tomoyuki Arai, Akira Shimizu, Kenji Hanyu, Sho Iwaki, Sae Imaizumi, Akihiro Sakai, Mayu Yamauchi, Ryoko Tanaka, Yuichiro Sato, Koji Yamamura, Mariko Sekimizu, Yorihisa Imanishi, Hideaki Hirai, Yukiko Sato, Makoto Urano, Hidetaka Yamamoto, Chihiro Fushimi, Takashi Matsuki, Toshitaka Nagao, Yuichiro Tada

2025Oral Oncology9 citationsDOIOpen Access PDF

Topics & Concepts

Salivary duct carcinomaAndrogen receptorMedicineOncologyInternal medicineCarcinomaOverall survivalCancer researchCancerProstate cancerSalivary Gland Tumors Diagnosis and TreatmentHead and Neck Cancer StudiesHER2/EGFR in Cancer Research
The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy | Litcius